Dublin, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "DNA Probes-Based Diagnostics - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 46 companies including many key and niche players such as
- Abbott Molecular (USA)
- Affymetrix, Inc. (USA)
- Beckman Coulter, Inc. (USA)
- Becton, Dickinson and Company (USA)
- bioMérieux (France)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- GE Healthcare Life Sciences (UK)
- Luminex Corporation (USA)
- QIAGEN N.V. (Netherlands)
- Siemens Healthineers (Germany)
Key Topics Covered: 1. MARKET DYNAMICS What are DNA-Probes? DNA-based Diagnostics A Prelude DNA Tests: Finding Use in Numerous Applications DNA Probes: Robust Growth Ahead Developed Markets: Traditional Revenue Contributors The United States: Unraveling the Country's Edge in DNA-based Diagnostics Infectious Diseases Tests Dominate the DNA-based Diagnostics Market Developing Countries Excel in Growth Prospects Decoding the Genetic Puzzle Advantages of DNA-Probe Tests Growth Drivers in a Nutshell Growth Inhibitors in a Nutshell Genetic Profiling of Pathogens: A Road Less Traveled Roche's Entry into the Hall of Molecular Fame DNA Technology: An Evolutionary Scan Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005 Market Opportunities 2. MARKET DRIVERS AND TRENDS World's Aging Population Drives the Popularity of DNA-Probe Tests Global Aging Population Statistics Opportunity Indicators Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics AIDS: A Global Epidemic Facts & Figures Reimbursements: Under the Umbrella Evolution of New & Virulent Infectious Agents Challenges in Widespread Deployment of DNA-based Diagnostics Improvements in Assay Capabilities Information Handling & Processing: The Soft Side of Diagnostics Integration: The Ultimate Challenge DNA Probe Technology Gains Prominence in Diagnosing Vaginitis Gene Banks A Ray of Hope for the Future 3. DNA PROBES-BASED DIAGNOSTICS - A PRIMER Diagnostic Gene Detection Products Molecular Diagnostics: A Powerful Disease Detection Tool DNA Probes-Based Products Direct Detection of Target Sequence Nucleic Acid Amplification Gene Detection Using DNA Chips Gene Detection by DNA Sequencing The Dynamics of Key Enabling Technologies Polymerase Chain Reaction (PCR) In situ Hybridization Chemiluminescence Gen-Probe Tigris DNA Chips Molecular Diagnostics A Primer Implications for Clinical Diagnostics Need of the Hour Impact of the Human Genome Project Tailored Patient Management: An Epitomized Future of Molecular Diagnostics Outlook 4. PRODUCT OVERVIEW Background Gene Probe Technology What is DNA? DNA Probes Miniaturization: A Revolutionary Method in DNA Analysis Gene Chip Technology DNA Chips Chromosome Painting Probes Diagnostic Applications Based on DNA Probes: An Overview Infectious Diseases Respiratory Tract Infections Diagnosis of Mycoplasma DNA Probes to Detect Legionella Pneumophila Detecting Tuberculosis through Rapid Diagnostic Tests How the Technique Works Limitations Sexually Transmitted Diseases (STDs) HIV HTLV-1 Testing Hepatitis Testing Chlamydia DNA Probes Detection of Intestinal Parasites Entamoeba Histolytica Salmonella Malaria Testing Identity/Forensics DNA Profiling: A Key Forensic Tool DNA-Based Forensic Diagnostics Tracing Human Origins Genetic Predisposition Molecular HLA Testing Human Leukocyte Antigen (HLA) Typing Cancer Testing Cancer: A Deadly Disease Afflicting Millions Slow Detoxifiers: Potential Cancer Candidates Improving Cancer Surgery through Diagnostic Tests Types of Cancer Chronic Lymphocytic Leukemia (CLL) Breast Cancer PCR Screening Technology for Breast Cancer Eye Cancers DNA Probes to Detect Retinoblastoma Others The Ames test Genetic Testing Other Diagnostic Applications Cystic Fibrosis Duchenne's Muscular Dystrophy Huntington's Disease Diabetes Detection of Multidrug Resistance Bacterial Resistance to Antibiotics 5. PRODUCT INTRODUCTIONS/INNOVATIONS DLCS Unveils In-House DNA Fish Test for Melanoma Agilent Technologies Introduces New SureFISH Break-Apart Probes Beckman Coulter Life Sciences Rolls Out PerFix-Expose1 and PerFix-nc1 6. RECENT INDUSTRY ACTIVITY Thermo Fisher Scientific Acquires Affymetrix Illumina Partners with Memorial Sloan Kettering Cancer Genetics to Acquire BioServe Biotechnologies Co-Diagnostics to Acquire DNA Logix' Technologies Leica Biosystems Takes Over Kreatech Diagnostics and Aotec 7. FOCUS ON SELECT GLOBAL PLAYERS Abbott Molecular (USA) Affymetrix, Inc. (USA) Beckman Coulter, Inc. (USA) Becton, Dickinson and Company (USA) bioMérieux (France) F. Hoffmann-La Roche Ltd. (Switzerland) GE Healthcare Life Sciences (UK) Luminex Corporation (USA) QIAGEN N.V. (Netherlands) Siemens Healthineers (Germany) 8. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 46 (including Divisions/Subsidiaries 57)
- The United States (37)
- Canada (2)
- Japan (1)
- Europe (13)
- - France (1)
- - Germany (3)
- - The United Kingdom (2)
- - Italy (1)
- - Spain (1)
- - Rest of Europe (5)
- Asia-Pacific (Excluding Japan) (4)
For more information about this report visit http://www.researchandmarkets.com/research/rm...robesbased Related Topics: Diagnostics
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
